⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1471055 | 0.75 | — | — | |
| SCHEMBL31321309 | 0.74 | — | — | |
| SCHEMBL8712173 | 0.70 | — | — | |
| SCHEMBL1425816 | 0.65 | — | — | |
| SCHEMBL12238381 | 0.65 | — | — | |
| SCHEMBL4317327 | 0.65 | — | — | |
| SCHEMBL11088371 | 0.65 | — | — | |
| SCHEMBL10595313 | 0.64 | FOLH1 (0.30) | — | |
| SCHEMBL9223745 | 0.63 | — | — | |
| SCHEMBL9223742 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104936617-A | CD33 antibodies and their use in treating cancer | SEATTLE GENETICS INC | 2015-09-23 | — | — | CN | disclosed |
| US-7714077-B2 | Triblock copolymer, method for producing the same, and biocompatible material | NOF CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
| EP-1642921-B1 | TRIBLOCK COPOLYMER, METHOD FOR PRODUCING THE SAME AND BIOCOMPATIBLE MATERIAL | NOF CORP (JP) | 2008-08-27 | — | — | EP | disclosed |
| US-20060223975-A1 | Tertiary block copolymer, process for producing the same, and biocompatible material | NOF CORPORATION (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1642921-A1 | TERTIARY BLOCK COPOLYMER, PROCESS FOR PRODUCING THE SAME AND BIOCOMPATIBLE MATERIAL | NOF CORPORATION (JP) | 2006-04-05 | — | — | EP | disclosed |